Aurora Financial Statements From 2010 to 2024

ASAPF Stock  USD 0.30  0.00  0.00%   
Aurora Spine financial statements provide useful quarterly and yearly information to potential Aurora Spine investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Aurora Spine financial statements helps investors assess Aurora Spine's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Aurora Spine's valuation are summarized below:
Aurora Spine does not presently have any fundamental signals for analysis.
Check Aurora Spine financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aurora Spine's main balance sheet or income statement drivers, such as , as well as many indicators such as . Aurora financial statements analysis is a perfect complement when working with Aurora Spine Valuation or Volatility modules.
  
This module can also supplement various Aurora Spine Technical models . Check out the analysis of Aurora Spine Correlation against competitors.

Aurora Spine OTC Stock Current Valuation Analysis

Aurora Spine's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Aurora Spine Current Valuation

    
  25.13 M  
Most of Aurora Spine's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aurora Spine is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Aurora Spine has a Current Valuation of 25.13 M. This is 99.83% lower than that of the Healthcare sector and 99.8% lower than that of the Medical Devices industry. The current valuation for all United States stocks is 99.85% higher than that of the company.

Aurora Spine Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Aurora Spine's current stock value. Our valuation model uses many indicators to compare Aurora Spine value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aurora Spine competition to find correlations between indicators driving Aurora Spine's intrinsic value. More Info.
Aurora Spine is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Aurora Spine's earnings, one of the primary drivers of an investment's value.

About Aurora Spine Financial Statements

Aurora Spine stakeholders use historical fundamental indicators, such as Aurora Spine's revenue or net income, to determine how well the company is positioned to perform in the future. Although Aurora Spine investors may analyze each financial statement separately, they are all interrelated. For example, changes in Aurora Spine's assets and liabilities are reflected in the revenues and expenses on Aurora Spine's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Aurora Spine. Please read more on our technical analysis and fundamental analysis pages.
Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of minimally invasive interspinous fusion systems and devices in Canada. Aurora Spine Corporation was incorporated in 2013 and is headquartered in Toronto, Canada. Aurora Spine is traded on OTC Exchange in the United States.

Currently Active Assets on Macroaxis

Other Information on Investing in Aurora OTC Stock

Aurora Spine financial ratios help investors to determine whether Aurora OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aurora with respect to the benefits of owning Aurora Spine security.